Boutique Diagnostics

Digital Health Market Access Consulting Firm

Digital Health Solutions

NICE

What are the key diagnostics access & policy developments from 2021?

What are the key diagnostics access & policy developments from 2021?

We regularly monitor diagnostics reimbursement and policy developments in various markets. At the end of the year, it is always good to take a pause and look back at the major initiatives. We find the following 7+1 initiatives relevant from 2021 (non-exhaustive list)

August 2021: What’s new in the world of diagnostics?

August 2021: What’s new in the world of diagnostics?

Exciting news flash from the world of (digital) diagnostics from market access, policy, product launches, start-ups and industry trends perspectives.

, ,

How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

, ,
How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

How does the UK's NICE evaluate diagnostic technologies? 1-pager summary

10 most exciting (digital) diagnostics news from 2019

10 most exciting (digital) diagnostics news from 2019

The top/best/most lists are always subjective, so is ours. Looking back to 2019 we enjoyed reading the following 10 news bites the most. This inventory is far from being comprehensive, yet they can point to broader trends.

What’s hot in (digital) diagnostics? – News in bullets, April - 2019

What’s hot in (digital) diagnostics? – News in bullets, April - 2019

We don’t perform comprehensive news monitoring but we aim to cover (digital) diagnostics topics relevant to us from various perspectives: (1) market access /health policy; (2) exciting product launches; (3) hot start-ups; (4) industry trends, major events.

Did we miss anything major that would fit in the buckets above? Please comment and enjoy the read!

, ,

Payer Trends in Diagnostics & Digital Health – What’s new?

, ,
Payer Trends in Diagnostics & Digital Health – What’s new?

Last year we released a blog post on 5 recent Payer trends in Diagnostics. What are the latest developments? Check out this short summary:

  1. Growing appetite for diagnostics health technology assessment in Europe

  2. Joint (regulator-payer) evidence reviews and scientific advice to MedTech manufacturers gain further momentum in the US

  3. Payers start to embrace Digital Health